Übersichtsarbeit
Controversies Surrounding IGF-I Receptor Involvement in Thyroid-Associated Ophthalmopathy
Thyroid® · 2025
DOI: 10.1089/thy.2024.0606 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Thyroid®, 2025. Verfasst von Terry J Smith. Beteiligte Einrichtung: Department of Ophthalmology and Visual Sciences, Kellogg Eye Center, Ann Arbor, Michigan, USA. Hauptthemen laut MEDLINE: Graves Ophthalmopathy, Receptor, IGF Type 1. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 140 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Graves OphthalmopathyReceptor, IGF Type 1HumansReceptors, ThyrotropinSignal TransductionAutoantibodiesAnimals
Stichwörter der Autor:innen
Graves’IGF-I receptorTSH receptordiseaseophthalmopathyteprotumumab
Substanzen
Receptor, IGF Type 1Receptors, ThyrotropinAutoantibodiesIGF1R protein, human
Autor:innen und Institutionen
- Department of Ophthalmology and Visual Sciences, Kellogg Eye Center, Ann Arbor, Michigan, USA.
- Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, Michigan, USA.
Zitieren
APA
Smith, T. J. (2025). Controversies Surrounding IGF-I Receptor Involvement in Thyroid-Associated Ophthalmopathy. Thyroid®. https://doi.org/10.1089/thy.2024.0606
Vancouver
Smith TJ. Controversies Surrounding IGF-I Receptor Involvement in Thyroid-Associated Ophthalmopathy. Thyroid®. 2025. doi:10.1089/thy.2024.0606
BibTeX
@article{Smith2025,
author = {Smith, Terry J},
title = {Controversies Surrounding IGF-I Receptor Involvement in Thyroid-Associated Ophthalmopathy},
journal = {Thyroid®},
year = {2025},
doi = {10.1089/thy.2024.0606}
}
EUVIMED